NCT07100210
- Conditions
- Interleukin, Refractory Malignant Solid Tumors, mRNA Vaccine
- Locations
-
- West China Hospital of Sichuan University Chengdu, Sichuan, China
Clinical trial condition
Interleukin
Explore clinical trials studying Interleukin. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Interleukin trial results
Completed
Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.
NCT07040943
- Conditions
- Interleukin, Refractory Malignant Solid Tumors, mRNA Vaccine
- Locations
-
- Department of Radiation Oncology Chengdu, Sichuan, China
- West China Hospital of Sichuan University Chengdu, Sichuan, China
NCT06811597
- Conditions
- Gingival Diseases, Gingival and Periodontal Disease, Gingivitis, +7 more
- Locations
-
- Afyonkarahisar Health Sciences University Afyonkarahisar, Turkey (Türkiye)
- Afyonkarahisar Health Science Afyonkarahisar, Turkey (Türkiye)
NCT03828877
- Conditions
- Interleukin, Neurologic Manifestations, Pain, +3 more
- Locations
-
- Kahramanmaras Sutcu Imam University Faculty of Medicine Kahramanmaraş, Onikişubat, Turkey (Türkiye)